{"id":"W3095480534","doi":"10.1016/j.jdcr.2020.10.032","title":"Asymptomatic SARS-CoV2 infection in a patient receiving risankizumab, an inhibitor of interleukin 23","year":2020,"lang":"en","type":"article","venue":"JAAD Case Reports","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Probity Medical Research; SKiN Health","funders":"","keywords":"Medicine; Immunosuppression; Psoriasis; Asymptomatic; Pandemic; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Ustekinumab; Immunology; 2019-20 coronavirus outbreak; Clarithromycin; Intensive care medicine; Dermatology; Internal medicine; Infliximab; Virology; Disease; Infectious disease (medical specialty); Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002038129,0.0001803005,0.0003631497,0.0001344095,0.00006109982,0.00001008773,0.00002939925,0.0002014131,0.00009740317],"category_scores_gemma":[0.0001672057,0.0001650206,0.0001098391,0.0002379644,0.00004578115,0.0001482106,0.00005289105,0.0001403429,0.00004051457],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000838441,"about_ca_system_score_gemma":0.00005997539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008041958,"about_ca_topic_score_gemma":0.000216082,"domain_scores_codex":[0.9984756,0.0002419568,0.0006730095,0.0003489052,0.0000443683,0.0002161363],"domain_scores_gemma":[0.9992111,0.00004521793,0.0003885572,0.0002770146,0.00004358817,0.00003455353],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000624393,0.001447714,0.3199247,0.0003007312,0.0005608441,0.07944095,0.01816491,0.0001018312,0.3948131,0.00002707342,0.00167802,0.1829158],"study_design_scores_gemma":[0.002401409,0.002288404,0.06338826,0.0003787115,0.0002937774,0.07079314,0.0004726591,0.00009259624,0.8550825,0.0001424275,0.004053324,0.0006128356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982721,0.0002402004,0.00003585214,0.00004114255,0.000706988,0.0003018483,0.00001120059,0.00007657021,0.0003141408],"genre_scores_gemma":[0.9996012,0.00002852866,0.00008245219,0.00006078589,0.00004304052,0.00004536658,0.00008927476,0.00001816387,0.00003116006],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4602694,"threshold_uncertainty_score":0.6729344,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02001887036858501,"score_gpt":0.252190622638426,"score_spread":0.232171752269841,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}